PRP Therapy for Osteoarthritis: Does Treatment with Your Own Plasma Help?

PRP Therapy for Osteoarthritis: Does Treatment with Your Own Plasma Help?

PRP therapy is often presented as one of the most promising modern methods for joint disease. Patients are attracted by the idea that the treatment uses their own blood and the body's own biological resources. This creates the expectation that the method is natural, safe and capable of restoring the joint.

In reality, PRP has both potential advantages and important limitations. It can help some patients with osteoarthritis reduce pain and improve joint function, but it is not a universal cure and cannot grow new cartilage in an already destroyed joint. To make a reasonable decision, it is important to understand how PRP works and when it is worth considering.

What is PRP therapy?

PRP stands for platelet-rich plasma. A small amount of the patient's blood is taken and processed in a centrifuge. This separates plasma with a higher concentration of platelets, which is then injected into the affected joint.

Platelets contain biologically active molecules, including growth factors. They may influence inflammation and tissue responses. The goal is to create a more favorable environment inside the joint and reduce symptoms.

Because the preparation is made from the patient's own blood, the risk of allergic reaction is low. However, this does not mean the method is suitable for everyone or that it can replace other treatment.

How can PRP help in osteoarthritis?

The expected effect is mainly symptom reduction. Some patients report less pain, better tolerance of walking and improved daily activity after a course of injections.

The mechanism is not the same as with corticosteroids or hyaluronic acid. PRP does not act as a rapid anti-inflammatory injection and does not work as a joint lubricant. Its effect, when it appears, usually develops gradually.

Study results remain mixed. Some trials show meaningful improvement in selected patients, while others demonstrate a modest or uncertain benefit. This is why PRP should be discussed individually, not recommended as a universal solution.

Who may benefit most?

PRP is more often considered in early or moderate osteoarthritis, when the joint is not severely deformed and there is still a reasonable range of motion. It may be useful when the main goal is to reduce pain and improve function while postponing more invasive treatment.

The result depends on disease stage, body weight, muscle strength, activity level and the type of pain. PRP is less likely to help when the joint is severely destroyed and pain is caused mainly by advanced mechanical damage.

Can PRP restore cartilage?

This is the most important misconception.

PRP should not be viewed as a method that restores destroyed hyaline cartilage. Even if pain decreases and function improves, this does not mean that the joint has been rebuilt.

The method may influence inflammation and biological processes, but it cannot return an advanced osteoarthritic joint to its original state. Therefore, PRP must be part of a comprehensive plan that includes exercise therapy, weight control and activity modification.

How is the procedure performed?

The procedure usually includes blood collection, centrifugation, preparation of platelet-rich plasma and injection into the joint under sterile conditions. Depending on the joint and clinical situation, ultrasound guidance may be used.

After the injection, mild soreness or temporary discomfort can occur. The physician gives recommendations about activity restriction and gradual return to normal load. The number of injections varies depending on the protocol and the patient's condition.

When should PRP not be overestimated?

PRP is sometimes promoted as an alternative to every other treatment. This is misleading. If pain is severe, the joint is markedly deformed or movement is sharply limited, PRP alone is unlikely to solve the problem.

It is also important not to repeat courses automatically if the effect is minimal. Lack of response after properly performed treatment suggests that another pain mechanism may be more important.

If PRP no longer provides relief

If PRP, medication, exercise therapy and other conservative measures do not control chronic pain, the treatment strategy should be reassessed.

In some patients, chronic pain persists because sensory nerve branches continue to transmit pain signals from the affected joint even when inflammation is not the main driver. In such cases, the physician may discuss radiofrequency denervation of joints (RFA).

RFA is not a regenerative treatment and does not replace the management of osteoarthritis. Its goal is to reduce chronic pain transmission. In properly selected patients, it can improve quality of life and reduce the need for repeated injections or constant medication.

Read more about radiofrequency denervation on the RFA service page.

Key Takeaways

PRP therapy can reduce pain and improve function in some patients with osteoarthritis, especially in earlier stages. It uses the patient's own plasma, but it should not be viewed as a guaranteed method of cartilage restoration.

If the effect is weak or short-lived, repeating PRP again and again is not always reasonable. The next step should be selected after reassessing the joint condition and the mechanism of chronic pain.
Arthroplasty from $10000